Michael Faia is the Project Management Lead (PML) for Defitelio® in Jazz Pharmaceuticals’s Hematology-Oncology franchise. Partnering with the Global Molecule Lead (GML), he is responsible for development of Defitelio®’s portfolio strategy, including a focus on lifecycle management and driving molecule value.
Previously, Michael has held leadership roles in operational excellence and project management with AstraZeneca (AZ). He was responsible for leading the Site Facilities, Maintenance, Engineering, and Validation teams along with oversight and accountability for the Pennsylvania site’s Project Management Office. Prior to joining AZ, Michael worked for Johnson & Johnson in roles ranging from engineering and production management to new product commercialization.
Michael earned his bachelor’s and master’s degrees in Chemical Engineering from Drexel University, a master’s degree in Quality from Temple University, and an MBA from Pennsylvania State University. Michael is a Pennsylvania licensed Professional Engineer (PE), a Certified Project Manager (PMP), Lean Six Sigma Black Belt (LSS BB), and Malcolm Baldrige National Quality Award Examiner.